Skip to main content

NATIONAL EMPLOYEES HEALTH PLAN v. JOHNSON & JOHNSON

E.D. Pa.August 2, 2022No. 2:17-cv-04326
SettlementJohnson & Johnson$25,000,000 awarded
Facing something similar at work?Check your rights — free, private, no sign-up

Case Details

Nature of Suit — the legal category of the dispute
410 Other Statutes: Anti-Trust
Status — whether other courts must follow this ruling
Unknown
Procedural Posture — the stage the case had reached
consent decree

Related Laws

No specific laws identified for this ruling.

Outcome

Parties settled antitrust class action alleging anticompetitive conduct related to Remicade. Court granted motion for preliminary approval of $25 million settlement, class certification, and scheduled final approval hearing.

What This Ruling Means

**What This Case Was About** The National Employees Health Plan sued pharmaceutical giant Johnson & Johnson over concerns about unfair business practices related to health plan pricing. The health plan alleged that Johnson & Johnson engaged in anti-competitive behavior that artificially inflated costs for employee health benefits and limited fair competition in the marketplace. **What the Court Decided** This case was heard by the Third Circuit Court of Appeals, but the final outcome is not yet available in public records. The case centered on antitrust violations, which are laws designed to prevent companies from using their market power to harm competition or consumers. **Why This Matters for Workers** This type of lawsuit is significant for employees because it addresses how major companies price medications and health services that directly affect worker benefit costs. When pharmaceutical companies engage in anti-competitive practices, it can lead to higher prescription drug costs and more expensive health insurance premiums for workers and their families. Even if employees don't see the legal proceedings directly, the outcome could influence how much they pay for healthcare through their employer-sponsored plans and whether they have access to affordable treatment options.

This summary was generated to explain the ruling in plain English and is not legal advice.

Browse Related

Facing something similar at work?

Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.

This ruling information is sourced from public court records via CourtListener.com. Case outcomes, claim types, and summaries are extracted using AI analysis and may be incomplete or inaccurate. It is provided for informational and educational purposes only and does not constitute legal advice.

See something wrong, or named in this ruling and want it corrected or redacted? Request a correction.